Novartis AG (NVS) Expands U.S. Manufacturing Footprint with New Texas Site
On May 7, NVS began construction on a 46,000-square-foot radioligand therapy manufacturing facility in Denton, Texas.
Novartis A G (NVS)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 13,885,749 | $2,121,048,400 | +86% | 0.72% |
| 2. | GQG Partners Rajiv Jain | 2,447,272 | $373,824,036 | -23% | 0.59% |
| 3. | 1,303,800 | $199,155,450 | +52% | 0.44% | |
| 4. | Renaissance Technologies Jim Simons | 1,111,833 | $169,832,491 | -18% | 0.27% |
| 5. | 714,700 | $109,170,425 | +61% | 0.02% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 8,527,037 | $1,302,505,395 | 0.08% | |
| 2. | 8,110,116 | $1,238,669,129 | 0.26% | |
| 3. | 7,567,354 | $1,155,913,327 | 0.91% | |
| 4. | 6,967,383 | $1,064,267,753 | 0.58% | |
| 5. | 6,525,771 | $996,811,494 | 0.11% |
News See All
10 Best Cancer Stocks to Buy for the Long Term
Pharmaceutical firms have always had a special place in the healthcare market because they provide stability and expansion.
14 Best Low Risk High Growth Stocks to Buy Right Now
The US economy is navigating a period of heightened volatility, defined by a sharp geopolitical tax on consumers and a resilient but stressed financial sector.
Novartis AG (NVS) Announces Final Two-Year Results From Phase III APPLAUSE‑IgAN Study
Novartis AG (NYSE:NVS) is one of the best pharma stocks to invest in now.
7 Best Pharma Stocks to Invest In Now
On March 24, Scott Chronert, Citi, appeared on CNBC’s 'Closing Bell' to talk about the market and whether it is time to get into equity markets.
Novartis (NVS) Announces Plans to Establish a New Radioligand Therapy Manufacturing Site in Denton, Texas
Novartis AG (NYSE:NVS) is one of the top gene therapy stocks to buy according to hedge funds.
Top 10 Gene Therapy Stocks to Buy According to Hedge Funds
On February 23, Lauren Goodwin, New York Life Investments, appeared on CNBC’s ‘Closing Bell’ to talk about the state of equity markets and tariff uncertainties.
Where is Novartis AG (NVS) Headed?
Novartis AG (NYSE:NVS) is one of the best immunotherapy stocks to buy according to hedge funds.
12 Best Immunotherapy Stocks to Buy According to Hedge Funds
On February 13, Matt Orton, Raymond James Investment Management's chief market strategist, appeared on CNBC’s ‘The Exchange’ to talk about the recent trends in equity markets and what may drive ...
Novartis AG (NYSE:NVS) Q4 2025 Earnings Call Transcript
Operator: Good morning and good afternoon, and welcome to the Novartis Q4 Full Year 2025 Results Release Conference Call and Live Webcast. [Operator Instructions] The conference is being recorded.
Hedge Fund Resource Center